Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
13,080,549
-
Number of holders
-
159
-
Total 13F shares, excl. options
-
12,322,577
-
Shares change
-
-200,357
-
Total reported value, excl. options
-
$573,859,683
-
Value change
-
-$7,942,717
-
Number of buys
-
62
-
Number of sells
-
87
-
Price
-
$46.57
Institutional Holders of EAGLE PHARMACEUTICALS, INC. - Common Stock (EGRX) as of Q4 2020
As of 31 Dec 2020 EAGLE PHARMACEUTICALS, INC. - Common Stock (EGRX) had 188 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 12,322,577 shares of stock of the company.
Largest 10 holders included BlackRock Inc., JANUS HENDERSON GROUP PLC, STATE STREET CORP, Park West Asset Management LLC, VANGUARD GROUP INC, ARMISTICE CAPITAL, LLC, Invesco Ltd., DIMENSIONAL FUND ADVISORS LP, BRANDES INVESTMENT PARTNERS, LP, and PRUDENTIAL FINANCIAL INC.
This table shows 188 institutional shareholders of the security as of 31 Dec 2020.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.